The Neutrino Donut recently completed the commercialization section for an SBIR grant for a client. The technology, relating to environmental technologies, required a summary of the market size, financial calculations on the ongoing revenue, identification of customers, evaluation of market entry strategies, and a full implementation plan.
The Neutrino Donut is providing business development services for multiple startups from Korea and India. We are working with these companies in establishing opportunities outside their countries.
The Neutrino Donut is developing the commercialization report for a startup in water technologies. The Donut will be developing the commercialization plan.
The Neutrino Donut is working on a project relating to develop a grant strategy program for a company developing medical software.
The Neutrino Donut has started advising multiple companies on the development of their grant programs. This is a six month consulting engagement and will involve identification of market development strategies and commercialization plans.
NIH SBIR/STTR Niche Assessment Program (NAP), I-Corps at NIH, and NIH SBIR/STTR Commercialization Accelerator Program (CAP).
A cornerstone of the SBIR and STTR programs is helping companies move along the path of commercialization, with an emphasis on reducing technology risk and increasing the value proposition. HHS offers the I-Corps TM at NIH program and the Niche Assessment Program for Phase I awardees, and the Commercialization Accelerator Program (CAP) for Phase II awardees.
Technologies supported by these programs include a range of drug, device, diagnostic or behavioral interventions.
This is where grant applicants have problems. They do not understand the process of taking their science into the marketplace. Issues such as product definition, pricing, scaling, customer identification, sales process, all are key topics for consideration. This is also where grant applications fail.
Contact us, we can help.
e hager 81 at gmail
The Neutrino Donut will be on two grant review panels later this fall, one for NIH and one for DoD. We will be reviewing the grants for commercialization opportunities.
The Neutrino Donut is working with NIH grant recipients on the development of their companies and technologies.